tetradecanoylphorbol acetate has been researched along with Wilms Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, KW; Charles, A; Charlet, J; Dallosso, A; Malik, K; Standen, GR; White, G | 1 |
| Cornwell, MM; McCoy, C; McGee, SB | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and Wilms Tumor
| Article | Year |
|---|---|
Characterization of 17.94, a novel anaplastic Wilms' tumor cell line.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis Regulatory Proteins; beta Catenin; Carcinoma; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Child, Preschool; DNA Methylation; Female; Humans; Karyotype; Neural Cell Adhesion Molecules; Nuclear Proteins; Tetradecanoylphorbol Acetate; Trans-Activators; Transcription Factors; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Vimentin; Wilms Tumor; WT1 Proteins | 2012 |
The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; DNA-Binding Proteins; Early Growth Response Protein 1; Gene Expression Regulation, Neoplastic; Genes, Wilms Tumor; Humans; Immediate-Early Proteins; K562 Cells; Promoter Regions, Genetic; Tetradecanoylphorbol Acetate; Transcription Factors; Wilms Tumor; WT1 Proteins; Zinc Fingers | 1999 |